Attachment 4b3 Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity DIMERIX LIMITED ABN/ARBN Financial year ended: 18 001 285 230 30...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Dimerix
- Dimerix Receives US$10M Upfront Payment from Everest
- Dimerix Assumes Sponsorship of US IND for New Asset DMX-652
- Dimerix Presents at Bioshares Summit 2026
- Dimerix Quarterly Activities Report and Appendix 4C
- US Patent Granted for Dimerix New Asset DMX-652
Later from Dimerix
- Appendix 4E and 2026 Annual Report
- Trading Halt
- Dimerix Secures A$34 Million Non-Dilutive Funding Facility
- Dimerix secures a$34 million non-dilutive facility to fund key clinical milestones
- S&P DJI Announces September 2026 Quarterly Rebalance
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix